These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4006813)

  • 21. Oxamniquine versus niridazole for treatment of uncomplicated Schistosoma mansoni infection.
    Kilpatrick ME; El Masry NA; Bassily S; Farid Z
    Am J Trop Med Hyg; 1982 Nov; 31(6):1164-7. PubMed ID: 7149102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
    da Silva LC; Sette H; Chamone DA; Sáez-Alquezar A; Punskas JA; Raia S
    Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006
    [No Abstract]   [Full Text] [Related]  

  • 23. Further experience on the use of oxamniquine in the treatment of advanced intestinal schistosomiasis.
    Farid Z; Bassily S; Higashi GI; el-Masry NA; Watten RH; Trabolsi B
    Ann Trop Med Parasitol; 1979 Oct; 73(5):501-2. PubMed ID: 534452
    [No Abstract]   [Full Text] [Related]  

  • 24. Field experiences with oral oxamniquine in the treatment of schistosomiasis mansoni.
    Coura JR; Argento CA; Conceição MJ; Lewis EM; dos Santos ML; Magalhães P
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):77-84, 195-202. PubMed ID: 7455514
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of oxamniquine in the treatment of S. mansoni infection among Sudanese patients.
    Ibrahim AM
    East Afr Med J; 1980 Aug; 57(8):566-73. PubMed ID: 7408738
    [No Abstract]   [Full Text] [Related]  

  • 26. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in Ethiopia.
    Ayele T
    East Afr Med J; 1984 Aug; 61(8):632-6. PubMed ID: 6399027
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of schistosomiasis mansoni with oxamniquine--five years' experience.
    Kilpatrick ME; Farid Z; Bassily S; El-Masry NA; Trabolsi B; Watten RH
    Am J Trop Med Hyg; 1981 Nov; 30(6):1219-22. PubMed ID: 7325280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schistosoma mansoni treatment with oral oxamniquine in Zambia.
    Gupta KK
    East Afr Med J; 1984 Aug; 61(8):641-4. PubMed ID: 6399028
    [No Abstract]   [Full Text] [Related]  

  • 29. Prophylactic-protective activity of oral oxamniquine against Schistosoma mansoni infection in hamsters.
    Girgis NI; Mansour NS; Kahlil SB
    East Afr Med J; 1979 Sep; 56(9):428-30. PubMed ID: 520260
    [No Abstract]   [Full Text] [Related]  

  • 30. Field use of oral oxamniquine in the treatment of S. mansoni.
    Eyakuze VM; Rutasitara WK; Ndalahwa JB
    East Afr Med J; 1979 Jan; 56(1):22-5. PubMed ID: 436702
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu].
    Queinnec J; Moyroud J
    Arch Inst Pasteur Madagascar; 1981; 48(1):143-9. PubMed ID: 7342891
    [No Abstract]   [Full Text] [Related]  

  • 32. Oxamniquine (Vansil) in the treatment of schistosomiasis in Rhodesia.
    de Clarke V
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):28-31, 144-7. PubMed ID: 7455506
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schistosomiasis control in Peri-Peri (Minas Gerais, Brazil) by repeated clinical treatment and molluscicide application.
    Katz N; Rocha RS; Pereira JP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):85-93, 203-11. PubMed ID: 7455515
    [No Abstract]   [Full Text] [Related]  

  • 36. Seizures associated with oxamniquine therapy.
    Stokvis H; Bauer AG; Stuiver PC; Malcolm AD; Overbosch D
    Am J Trop Med Hyg; 1986 Mar; 35(2):330-1. PubMed ID: 3082231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxamniquine in the treatment of schistosomiasis in a population in area with low endemicity.
    Bina JC; Prata A
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):94-7, 212-6. PubMed ID: 7455516
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxamniquine treatment in experimental schistosomiasis mansoni. Biological, morphological and pathological changes induced by divided doses.
    Mikhail EG; Sabet S; Mahran SG; Gaber AA; Soliman AA; Zaki IE; Tadros MB
    J Egypt Soc Parasitol; 1981 Jun; 11(1):33-49. PubMed ID: 7299160
    [No Abstract]   [Full Text] [Related]  

  • 40. Migration and fate of Schistosoma mansoni in mice treated with oxaminiquine.
    Oliveira MA; Pellegrino J; Pereira LH; Valadares TE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):298-300. PubMed ID: 1006062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.